Immunometabolic control of macrophage plasticity in wound healing: mechanistic insights and therapeutic opportunities - Summary - MDSpire

Immunometabolic control of macrophage plasticity in wound healing: mechanistic insights and therapeutic opportunities

  • By

  • Lijing Shi

  • Hongyou Zhou

  • Rui Zheng

  • July 13, 2026

Share

Objective:

To explore how metabolic reprogramming of macrophages influences their plasticity and roles in wound healing and tissue repair, focusing on the underlying mechanisms.

Approach:
  • Macrophage Plasticity and Effector Programs: Describes the diversity of macrophage effector programs and their roles in tissue repair across four stages: hemostasis, inflammation, proliferation/repair, and remodeling.
  • Signaling Pathways: Analyzes signaling pathways that regulate macrophage effector programs, emphasizing metabolic reprogramming and the role of mTOR as a metabolic hub.
  • Therapeutic Potential: Examines strategies for targeting macrophage metabolic reprogramming to modulate the wound microenvironment and address chronic wounds, fibrotic diseases, and inflammatory disorders.
Key Findings:
  • Macrophages transition from a pro-inflammatory to an anti-inflammatory phenotype through metabolic reprogramming.
  • Glycolysis and oxidative phosphorylation are critical for macrophage function and phenotype shifts.
  • Persistent activation of macrophages can lead to tissue damage or fibrosis.
Interpretation:

Metabolic reprogramming is crucial for macrophage plasticity and effective tissue repair, presenting a potential therapeutic target for various inflammatory and fibrotic conditions.

Limitations:
  • The review does not systematically explain how metabolic reprogramming drives the transition of macrophage effector programs.
  • It lacks a comprehensive examination of the direct mechanistic links between metabolic changes and repair outcomes.
Conclusion:

Understanding the metabolic regulation of macrophages can inform new therapeutic strategies for enhancing tissue repair and managing chronic inflammatory conditions.

Original Source(s)

Related Content